D. Zou et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 98 (2012) 359–366
361
the respective solution at room temperature and pale yellow
microcrystallines 1–2 were obtained in about three weeks, respec-
tively. For 1: Yield: 0.065 g, 68%. Calc. for C33H27N8O13ZnNd: C,
41.58; H, 2.85; N, 11.75%; found: C, 41.69; H, 2.91; N, 11.76%. IR
(KBr, cmÀ1): 3270 (w), 2336 (w), 2103 (w), 1895 (w), 1769 (w),
1652 (m), 1625 (m), 1609 (m), 1571 (m), 1540 (m), 1453 (vs),
1385 (s), 1318 (s), 1303 (s), 1201 (m), 1180 (m), 1162 (m), 1120
(w), 1092 (m), 1055 (s), 991 (m), 931 (w), 909 (w), 863 (m), 846
(m), 817 (w), 782 (m), 744 (s), 703 (m), 658 (m), 630 (w), 561
(w), 539 (w), 508 (m), 442 (m), 420 (m). 1H NMR (400 MHz, CD3-
CN): d (ppm) 14.59 (s, 2H), 9.40 (d, 2H), 8.61 (m, 2H), 7.72 (m,
4H), 7.61 (m, 2H), 7.48 (m, 2H), 6.92 (m, 3H), 6.46 (m, 2H), 5.72
(m, 2H), À2.65 (s, 6H). ESI-MS (CH3CN) m/z: 950.01 ([MÀH]+,
100%). For 2: Yield: 0.060 g, 62%. Calc. for C33H27N8O13ZnGd: C,
41.02; H, 2.82; N, 11.60%; found: C, 40.98; H, 2.86; N, 11.58%. IR
(KBr, cmÀ1): 3427 (w), 2318 (w), 2041 (w), 1967 (w), 1765 (w),
1637 (m), 1616 (m), 1585 (m), 1571 (m), 1551 (m), 1522 (m),
1457 (vs), 1387 (s), 1330 (s), 1303 (s), 1286 (m), 1263 (m), 1234
(m), 1195 (m), 1167 (m), 1120 (w), 1096 (m), 1074 (m), 1023
(m), 966 (m), 850 (m), 815 (w), 784 (m), 740 (s), 666 (m), 648
(w), 632 (w), 582 (w), 556(w), 540 (w), 512 (m), 442 (m), 415
(m). ESI-MS (CH3CN) m/z: 966.03 ([MÀH]+, 100%).
1179 (m), 1059 (m), 986 (s), 847 (m), 798 (s), 766 (vs), 703 (s),
634 (m), 566 (m), 507 (s), 454 (m). 1H NMR (400 MHz, CD3CN): d
14.71 (s, 2H, –NH), 9.42 (s, 1H, –Ph), 8.62 (s, 2H, –Ph), 7.75 (d,
2H, –Ph), 7.60 (t, 2H, –Ph), 7.49 (t, 2H, –Ph), 7.10 (t, 2H, –Ph),
6.42 (m, 4H, –Ph), 5.67 (s, 2H, –Ph), -3.14 (s, 6H, –MeO). ESI-MS
(CH3CN) m/z: 1105.84 ([MÀH]+, 100%). For 4: Yield: 0.055 g, 62%.
Calc. for C33H25Br2N8O13ZnGd: C, 35.26; H, 2.24; N, 9.97%; found:
C, 35.25; H, 2.31; N, 9.91%. IR (KBr, cmÀ1): 3316 (w), 3090 (w),
2932 (w), 2110 (w), 1936 (w), 1594 (m), 1480 (w), 1451 (s),
1385 (m), 1317 (m), 1248 (s), 1179 (m), 1060 (m), 986 (s), 847
(m), 799 (vs), 746 (vs), 703 (vs), 634 (m), 545 (m), 508 (s), 452
(m). ESI-MS (CH3CN) m/z: 1121.85 ([MÀH]+, 100%).
X-ray crystallography
Single crystals of 1Á1.5MeOHÁ1.5H2OÁ0.5Py and 3ÁPy of suitable
dimensions were mounted onto thin glass fibers. All the intensity
data were collected on a Bruker SMART CCD diffractometer
(Cu-K
a
radiation and k = 1.54184 Å for 1Á1.5MeOHÁ1.5H2OÁ0.5Py;
Mo-K
a
radiation and k = 0.71073 Å for 3ÁPy) in and scan
U
x
modes. Structures were solved by direct methods followed by
difference Fourier syntheses, and then refined by full-matrix
least-squares techniques against F2 using SHELXTL [13]. All other
non-hydrogen atoms were refined with anisotropic thermal
parameters. Absorption corrections were applied using SADABS
[14]. All hydrogen atoms were placed in calculated positions and
refined isotropically using a riding model. Crystallographic data
and refinement parameters for the complexes are presented in Ta-
ble 1. Relevant atomic distances and bond angles are collected in
Table 2.
2-(1H-benzo[d]imidazol-2-yl)-4-bromo-6-methoxyphenol (H2L2)
The benzimidazole-based ligand H2L2 was prepared in the same
way as that of H2L1 except o-phenylenediamine (2.16 g, 20 mmol)
and
5-bromo-2-hydroxy-3-methoxybenzaldehyde
(4.62 g,
20 mmol) were used. The off-white microcrystalline precipitate
was obtained by washing with absolute EtOH and diethyl ether.
Yield: 1.62 g, 70%. Calc. for C14H11BrN2O2: C, 52.69; H, 3.47; N,
8.78%; found: C, 52.66; H, 3.49; N, 8.77%. IR (KBr, cmÀ1): IR (KBr,
cmÀ1): 3934 (w), 3362 (w), 2473 (w), 2344 (w), 1922 (w), 1628
(m), 1464 (m), 1444 (m), 1385 (m), 1327 (s), 1249 (vs), 1114
(m), 983 (s), 911 (m), 825 (vs), 735 (vs), 708 (vs), 601 (v), 548
(w). 1H NMR (400 MHz, CD3CN): d 13.65 (s, H, –NH), 13.40 (s, 1H,
–OH), 7.63 (d, 1H, –Ph), 7.49 (d, 1H, –Ph), 7.37 (m, 1H, –Ph), 7.31
(m, 1H, –Ph), 7.12 (m, 2H, –Ph), 3.93 (s, 3H, –MeO).
Results and discussion
Synthesis and characterization
As shown in Scheme 1, treatment of o-phenylenediamine with
o-vanillin or 5-bromo-2-hydroxy-3-methoxybenzaldehyde in 1:1
molar ratio in absolute EtOH at ambient temperature and the sub-
The precursor of [Zn(HL2)2(Py)]
The method was similar to that used for [Zn(HL1)2(Py)] (above).
H2L2 (319 mg, 1 mmol), Zn(OAc)2Á2H2O (110 mg, 0.5 mmol) and Py
(2 ml) were employed. Finally, the yellow precipitate was filtered
out, washed with absolute EtOH and CHCl3, and dried under vac-
uum. For [Zn(HL2)2(Py)]: yield: 245 mg, 70%. Calc. for C33H25Br2N5-
O4Zn: C, 50.76; H, 3.23; N, 8.97%; found: C, 50.70; H, 3.31; N, 8.98%.
IR (KBr, cmÀ1): 3436 (w), 3184 (w), 2930 (w), 2343 (w), 2119 (w),
1626 (m), 1530 (s), 1471 (m), 1382 (w), 1313 (s), 1232 (vs), 1179
(m), 1069 (s), 1000 (w), 887 (m), 841 (m), 799 (vs), 740 (vs), 634
(m), 567 (m), 508 (s), 419 (s). 1H NMR (400 MHz, CD3CN): d
13.49 (s, 2H, –NH), 8.57 (s, 1H, –Ph), 7.82 (s, 2H, –Ph), 7.58 (d,
2H, –Ph), 7.39 (t, 2H, –Ph), 7.26 (t, 2H, –Ph), 7.14 (t, 2H, –Ph),
7.09 (m, 4H, –Ph), 6.98 (s, 2H, –Ph), 3.70 (s, 6H, –MeO).
Table 1
Crystallographic data and refinement parameters for complexes 1Á1.5MeOHÁ1.5H2-
OÁ0.5Py and 3ÁPy.
Compound
1Á1.5MeOHÁ1.5H2OÁ0.5Py 3ÁPy
Empirical formula
Formula weight
Crystal system
Space group
k/Å
a/Å
b/Å
c/Å
C
37H38.5N8.5O16ZnNd
C38H30N9O13Br2ZnNd
1090.14
1067.87
Triclinic
Triclinic
P-1
P-1
1.54184
0.71073
11.4753(6)
15.6752(9)
26.4003(16)
93.742(5)
90.597(5)
106.176(5)
4549.1(4)
4
11.407(4)
14.335(5)
15.257(6)
106.740(7)
103.261(7)
91.570(7)
2313.7(15)
2
aꢀ/
bꢀ/
[ZnLn(HL2)2(Py)(NO3)3] (Ln = Nd, 3; Ln = Gd, 4)
c
ꢀ/
V/Å3
To a stirred solution of [Zn(HL2)2(Py)] (0.078 g, 0.10 mmol) in
absolute MeCN (5 ml), the solution of Ln(NO3)3 6H2O (0.10 mmol,
Ln = Nd, 0.043 g or Ln = Gd, 0.044 g) in absolute acetone (4 ml)
was added, and the mixture was refluxed about 3 h. The respective
yellow clear solution was then cooled to room temperature and fil-
tered. Diethyl ether was allowed to diffuse slowly into the respec-
tive solution at room temperature and pale yellow
microcrystallines 3 or 4 was obtained after three weeks, respec-
tively. For 3: Yield: 0.080 g, 71%. Calc. for C33H25Br2N8O13ZnNd:
C, 35.67; H, 2.27; N, 10.09%; found: C, 35.72; H, 2.33; N, 10.08%.
IR (KBr, cmÀ1): 3310 (w), 3090 (w), 2935 (w), 2114 (w), 1935
(w), 1595 (m), 1474 (w), 1457 (s), 1385 (m), 1314 (s), 1248 (s),
Z
q
/g cmÀ3
1.559
1.708
Crystal size/mm
0.31 Â 0.27 Â 0.23
0.28 Â 0.26 Â 0.22
l
/mmÀ1
9.916
3.424
Data/restraints/
parameters
Quality-of-fit indicator
No. Unique reflections
No. Observed reflections
8748/0/1144
8139/0/548
1.020
0.970
8748
8139
10321
11489
Final R indices [I > 2
r
(I)]
R1 = 0.0863
WR2 = 0.2289
R1 = 0.1015
WR2 = 0.2484
R1 = 0.0975
WR2 = 0.2227
R1 = 0.2289
WR2 = 0.3097
R indices (all data)